2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
[HTML][HTML] Teplizumab and β-cell function in newly diagnosed type 1 diabetes
EL Ramos, CM Dayan, L Chatenoud… - … England Journal of …, 2023 - Mass Medical Soc
Background Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved
by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) …
by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) …
[HTML][HTML] Baricitinib and β-cell function in patients with new-onset type 1 diabetes
M Waibel, JM Wentworth, M So… - … England Journal of …, 2023 - Mass Medical Soc
Background Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and
are effective disease-modifying treatments for several autoimmune diseases. Whether …
are effective disease-modifying treatments for several autoimmune diseases. Whether …
[PDF][PDF] Care in diabetes—2022
D Care - Diabetes care, 2022 - healthy.arkansas.gov
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
100 years of insulin: celebrating the past, present and future of diabetes therapy
The year 2021 marks the centennial of Banting and Best's landmark description of the
discovery of insulin. This discovery and insulin's rapid clinical deployment effectively …
discovery of insulin. This discovery and insulin's rapid clinical deployment effectively …
An autoimmune stem-like CD8 T cell population drives type 1 diabetes
CD8 T cell-mediated autoimmune diseases result from the breakdown of self-tolerance
mechanisms in autoreactive CD8 T cells. How autoimmune T cell populations arise and are …
mechanisms in autoreactive CD8 T cells. How autoimmune T cell populations arise and are …
Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation
Mass-spectrometry-based proteomic analysis is a powerful approach for discovering new
disease biomarkers. However, certain critical steps of study design such as cohort selection …
disease biomarkers. However, certain critical steps of study design such as cohort selection …
Screening for type 1 diabetes in the general population: a status report and perspective
Most screening programs to identify individuals at risk for type 1 diabetes have targeted
relatives of people living with the disease to improve yield and feasibility. However,∼ 90 …
relatives of people living with the disease to improve yield and feasibility. However,∼ 90 …
[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.
ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …